Borregaard ASA

Borregaard ASA

141.70
NOK
-2.50
(-1.73%)
15.00BMarket Cap
Oct 28Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
38.22
38.48
40.75
43.91
45.22
47.05
49.51
52.48
57.38
67.96
70.44
75.25
76.02
- -
Basic EPS, GAAP
3.35
3.34
3.86
5.55
5.66
4.76
4.17
4.38
6.95
8.95
8.73
8.25
6.22
- -
Free Cash Flow per Basic Share
2.38
2.87
1.33
4.59
-1.88
-2.04
1.14
3.85
8.79
2.72
8.99
3.58
5.65
- -
Dividend per Share
1
1.09
1.24
1.49
3.49
1.99
2.24
2.3
2.5
5
3.25
3.75
4.25
4.76
Book Value per Share
18.71
19.56
20.66
26.88
29.03
31.37
33.18
36.82
42.4
44.13
48.76
50.64
58.69
56.09
Tangible Book Value per Share
18.13
18.79
19.29
25.63
27.92
30.37
32.25
35.96
41.5
43.31
47.92
49.75
57.9
55.36
Basic Weighted Avg Shares
100
100
100
100
100
100
100
100
100
100
100
100
100
100
Sales/Revenue/Turnover
3,822
3,848
4,075
4,391
4,522
4,705
4,951
5,227
5,715
6,776
7,024
7,502
7,580
- -
Operating Margin (%)
12.74
12.63
12.17
15.55
16.48
12.24
11.82
13.09
16.66
17.62
18.38
17.5
16.98
- -
Depreciation Expense
231
244
269
278
316
327
432
449
420
449
490
561
591
- -
Net Income, GAAP
335
334
386
555
566
476
417
436
692
892
870
823
620
- -
Effective Tax Rate (%)
28.04
22.79
24.11
23.62
21.96
24.38
24.84
23.59
24.4
23.88
23.84
23.17
30.56
- -
Profit Margin (%)
8.77
8.68
9.47
12.64
12.52
10.12
8.42
8.34
12.11
13.16
12.39
10.97
8.18
- -
Working Capital
621
666
785
705
568
654
502
592
740
916
1,313
1,152
1,447
1,372
LT Debt
774
784
802
525
743
1,115
1,419
1,381
1,320
1,370
2,016
2,035
1,718
1,646
Total Equity
1,856
1,949
2,061
2,713
2,996
3,321
3,464
3,778
4,306
4,445
4,894
5,090
5,878
5,610
Return on Invested Capital (%)
12.9
12.47
13.86
17.85
14.9
9.57
7.98
7.47
11.9
13.97
13.81
13.05
11.16
- -
Return on Capital (%)
13.84
13.45
14.56
18.6
16.13
12.7
10.61
9.82
13.25
16.17
14.84
13.25
9.73
- -
Return on Common Equity (%)
18.94
17.63
19.31
23.44
20.33
15.83
12.97
12.5
17.54
20.71
18.81
16.63
11.38
- -

Capital Structure

NOK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
463
454
620
LT Borrowings
1,718
1,737
1,646
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
100
100
100
Market Capitalization
19,821
17,610
14,997

Working Capital

NOK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,128
3,474
3,205
Cash, Cash Equivalents & STI
90
61
125
Accounts Receivable, Net
1,095
1,757
1,684
Inventories
1,521
1,472
1,396
Total Current Liabilities
1,681
1,659
1,833
Payables & Accruals
- -
- -
- -
ST Debt
463
454
620
Deferred Revenue
- -
- -
- -

Growth Rates

NOK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.31%
9.36%
15.48%
Free Cash Flow
48.03%
57.52%
57.7%
Net Income, GAAP
7.71%
11.02%
-24.67%
Sales/Revenue/Turnover
6.5%
7.88%
1.04%
Total Cash Common Dividend
22.91%
20.57%
13.37%

Quarterly Revenue

NOK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,975
1,949
1,949
1,744
7,502
2025
2,036
2,045
- -
1,833
7,580
2026
2,005
2,114
- -
- -
- -

Quarterly Earnings Per Share

NOK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.01
2.45
2.51
1.3
8.25
2025
2.51
2.56
- -
-0.81
6.22
2026
1.82
-1.27
- -
- -
- -

Quarterly Dividends Per Share

NOK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
3.76
- -
- -
3.75
2025
- -
4.26
- -
- -
4.25
2026
- -
4.75
- -
- -
- -

Company Description

CEO
Tom Erik Foss-Jacobsen
Full Time Employees
1,228
Sector
Process industries
Industry
Chemicals: major diversified
Address
PO Box 162 Sarpsborg OE Norway 1701
IPO Date
Oct 18, 2012
Business
Borregaard ASA Borregaard ASA operates one of the world's most advanced and sustainable biorefineries, producing biobased specialty chemicals and biomaterials from renewable wood raw materials as alternatives to oil-based products; core offerings span lignin-based binding and dispersing agents such as lignosulfonates for industries including agriculture, construction, batteries, and aquaculture; high-purity speciality cellulose for cellulose ethers, acetate, and other derivatives; microfibrillated cellulose fibrils for rheology, stability, strength, and barrier applications; biovanillin derived from PEFC-certified Norway Spruce for flavors, fragrances, food, and beverages; and highly sustainable second-generation bioethanol with emissions approximately one-tenth of synthetic variants. The company serves over 3,000 customers across more than 100 countries with operations encompassing 13 countries in Europe, Asia, and the Americas, including production facilities in Sarpsborg, Norway—its headquarters and primary biorefinery site established in 1889—along with sites in the United States, Germany, and sales offices worldwide; it organizes into three segments: BioSolutions for biopolymers and biovanillin, BioMaterials for speciality cellulose, and Fine Chemicals for intermediates targeting pharmaceuticals, cosmetics, and biofuels. Recent developments include Board approval in 2025 for a capacity expansion at the Sarpsborg site anticipated to increase core lignin-based production by 5% to 10%; participation in a convertible loan to Alginor ASA to support its biorefinery project; receipt of a NOK 15 million grant in September 2025 for the Biomer project advancing biobased innovations; appointment of a new CEO in August 2025 to reinforce specialization and value growth strategies; and a long-term power supply contract with Hafslund announced in September 2024 to underpin operational sustainability.

Company News

  • Borregaard ASA (BRGAY) Discusses Outlook for BioSolutions and BioMaterials, Market Trends, and Volume Expectations Transcript

  • Borregaard ASA (OTCMKTS:BRRDF) Short Interest Up 27.3% in February

  • Borregaard ASA (BRGAY) Q4 2025 Earnings Call Transcript

  • Borregaard ASA (BRGAY) Discusses BioSolutions Segment Outlook and Margin Dynamics Ahead of Close Transcript

  • Borregaard ASA (BRGAY) Q3 2025 Earnings Call Transcript

  • Borregaard ASA - Special Call